IDEXX Laboratories Jumps 15% on Q3 Earnings Beat

Core Insights - IDEXX Laboratories (NASDAQ: IDXX) reported Q3 results that exceeded both EPS and revenue expectations, continuing its streak of earnings beats [1] - The company raised its full-year guidance following the strong quarterly performance [1] Financial Performance - The Q3 earnings report highlighted a significant performance improvement, with both EPS and revenue surpassing market expectations [1] - The specific figures for EPS and revenue were not disclosed in the provided content, but the overall performance indicates a positive trend for the company [1] Future Outlook - IDEXX Laboratories has increased its full-year guidance, suggesting confidence in continued growth and performance for the remainder of the fiscal year [1]